FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to methods for producing a population of cells highly sensitive to Clostridial neurotoxin, as well as determining the activity of the modified or recombinant neurotoxin and identifying the composition of the Clostridial neurotoxin for therapeutic and/or cosmetic use.
EFFECT: invention enables to obtain cell populations having high sensitivity to clostridial neurotoxins for use in analyses.
54 cl, 14 dwg, 13 ex
| Title |
Year |
Author |
Number |
| GENETICALLY ENGINEERED CELLS SENSITIVE TO CLOSTRIDIAL NEUROTOXINS |
2020 |
- Ojler, Dzhordzh E.
- Gertts, Barri
|
RU2824389C2 |
| TREATMENT OF SKIN DISEASES |
2021 |
- Maignel, Jacquie
- Krupp, Johannes
|
RU2840027C1 |
| NON-TOXIC POLYPEPTIDES OF CLOSTRIDIAL NEUROTOXIN FOR USE IN TREATING NEUROLOGICAL DISORDERS |
2020 |
- Fonfria Subiros, Elena
- Lewandowska, Agnieszka
|
RU2839368C1 |
| THERAPEUTIC AND COSMETIC USE OF SEROTYPE E NEUROTOXIN BOTULINUM |
2019 |
|
RU2800604C2 |
| METHODS FOR PRODUCING PROTEOLYTICALLY PROCESSED POLYPEPTIDES |
2018 |
|
RU2719164C1 |
| METHODS FOR PRODUCING PROTEOLYTICALLY PROCESSED POLYPEPTIDES |
2019 |
|
RU2727402C1 |
| MODIFIED BOTULINUM NEUROTOXIN FOR TREATING EXTREMITY SPASTICITY |
2021 |
- Grigore, Nicolae
- Ruffle, Katie
- Picaut, Philippe
|
RU2841585C1 |
| CONSTRUCTED BOTULINUM NEUROTOXIN |
2017 |
|
RU2789302C2 |
| HYBRID NEUROTOXINS |
2017 |
- Fonfria Subiros, Elena
- Burgin, David
|
RU2782382C2 |
| ENGINEERED BOTULINUM NEUROTOXIN |
2016 |
- Dong Min
- Peng Lisheng
- Tao Liang
|
RU2746736C2 |
